Morinidazole

Drug Profile

Morinidazole

Alternative Names: Lingda

Latest Information Update: 10 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Jiangsu Hansoh Pharmaceutical
  • Class Anti-infectives; Nitroimidazoles
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Bacterial infections

Most Recent Events

  • 04 Aug 2017 Launched for Bacterial infections in China before August 2017 (unspecified route)
  • 04 Aug 2017 Zhejiang University and Shanghai Hansoh Biomedical plan a phase I trial in Healthy volunteers in (ChiCTR-IIR-17012161)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top